Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

Published:2017-01 Issue:1 Volume:265 Page:185-191
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Allen Peter J.,Kuk Deborah,Castillo Carlos Fernandez-del,Basturk Olca,Wolfgang Christopher L.,Cameron John L.,Lillemoe Keith D.,Ferrone Cristina R.,Morales-Oyarvide Vicente,He Jin,Weiss Matthew J.,Hruban Ralph H.,Gönen Mithat,Klimstra David S.,Mino-Kenudson Mari

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference15 articles.

1. Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement;Adsay;Semin Diagn Pathol,2012

2. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories;Strobel;Ann Surg,2015

3. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma;Murakami;J Am Coll Surg,2010

4. Substaging of lymph node status in resected pancreatic ductal adenocarcinoma has strong prognostic correlations: proposal for a revised N classification for TNM staging;Basturk;Ann Surg Oncol,2015

5. Regression modelling strategies for improved prognostic prediction;Harrell;Stat Med,1984

Cited by 387 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor burden score is superior to primary liver cancer stages in predicting prognosis for patients with combined hepatocellular-cholangiocarcinoma after surgery: A multi-center study;European Journal of Surgical Oncology;2024-11

2. Surgical Palliation for Advanced Pancreas Cancer;Surgical Clinics of North America;2024-10

3. The Value of PET/CT Radiomics for Predicting Survival Outcomes in Patients with Pancreatic Ductal Adenocarcinoma;2024-09-12

4. Prevalence of germline variants in Brazilian pancreatic carcinoma patients;Scientific Reports;2024-09-10

5. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer;Cancer Cell;2024-09